Related references
Note: Only part of the references are listed.Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
Improved MRI quantification of spinal cord atrophy in multiple sclerosis
Hugh Kearney et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
Ultra-high-field MR imaging in multiple sclerosis
Massimo Filippi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'
Marita Daams et al.
CURRENT OPINION IN NEUROLOGY (2013)
Clinical use of brain volumetry
Antonio Giorgio et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
Maria Pia Sormani et al.
LANCET NEUROLOGY (2013)
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab
Tom Button et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis
Robert A. Brown et al.
NEUROIMAGE (2013)
Clinically feasible MTR is sensitive to cortical demyelination in MS
Jacqueline Tien-Hsiang Chen et al.
NEUROLOGY (2013)
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials
Leonard H. Verhey et al.
NEUROLOGY (2013)
Gray matter damage predicts the accumulation of disability 13 years later in MS
Massimo Filippi et al.
NEUROLOGY (2013)
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients
Carsten Lukas et al.
RADIOLOGY (2013)
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
Tarek A. Yousry et al.
ANNALS OF NEUROLOGY (2012)
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis
Ernst-Wilhelm Radue et al.
ARCHIVES OF NEUROLOGY (2012)
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine
T. Hayton et al.
JOURNAL OF NEUROLOGY (2012)
Evolution of MS lesions to black holes under DNA vaccine treatment
Athina Papadopoulou et al.
JOURNAL OF NEUROLOGY (2012)
Modelling the distribution of cortical lesions in multiple sclerosis
MariaPia Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis
M. Calabrese et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis
F. Rinaldi et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2012)
Neuroplasticity and functional recovery in multiple sclerosis
Valentina Tomassini et al.
NATURE REVIEWS NEUROLOGY (2012)
Postmortem verification of MS cortical lesion detection with 3D DIR
A. Seewann et al.
NEUROLOGY (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multiple Sclerosis: Effects of Cognitive Rehabilitation on Structural and Functional MR Imaging Measures-An Explorative Study
Massimo Filippi et al.
RADIOLOGY (2012)
Relating Brain Damage to Brain Plasticity in Patients With Multiple Sclerosis
Valentina Tomassini et al.
NEUROREHABILITATION AND NEURAL REPAIR (2012)
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability
Stefan D. Roosendaal et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
M. P. Sormani et al.
NEUROLOGY (2011)
A multicenter assessment of cervical cord atrophy among MS clinical phenotypes
M. A. Rocca et al.
NEUROLOGY (2011)
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
M. Filippi et al.
NEUROLOGY (2011)
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI
J. J. G. Geurts et al.
NEUROLOGY (2011)
Intercenter Differences in Diffusion Tensor MRI Acquisition
Elisabetta Pagani et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis
I. J. van den Elskamp et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis
Mark A. Horsfield et al.
NEUROIMAGE (2010)
Surrogate endpoints for EDSS worsening in multiple sclerosis A meta-analytic approach
M. P. Sormani et al.
NEUROLOGY (2010)
Intracortical lesions Relevance for new MRI diagnostic criteria for multiple sclerosis
M. Filippi et al.
NEUROLOGY (2010)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
Abnormal Connectivity of the Sensorimotor Network in Patients With MS: A MultiCenter fMRI Study
Maria A. Rocca et al.
HUMAN BRAIN MAPPING (2009)
A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis
Claudia C. Kaiser et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate
D. Cadavid et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis
S. Cader et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
X. Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study
C. Wegner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
A three-year, multi-parametric MRI study in patients at presentation with CIS
Maria A. Rocca et al.
JOURNAL OF NEUROLOGY (2008)
Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study
B. R. Sajja et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
N. De Stefano et al.
NEUROLOGY (2007)
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study
L. Roccatagliata et al.
MULTIPLE SCLEROSIS (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis
J. T. Chen et al.
NEUROLOGY (2006)
Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a
M Hardmeier et al.
NEUROLOGY (2005)
Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis
CM Dalton et al.
JOURNAL OF NEUROLOGY (2004)
European study on intravenous immunoglobulin in multiple sclerosis - Results of magnetization transfer magnetic resonance imaging analysis
M Filippi et al.
ARCHIVES OF NEUROLOGY (2004)
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
MP Amato et al.
NEUROLOGY (2004)
Spinal-cord MRI in multiple sclerosis
G Lycklama et al.
LANCET NEUROLOGY (2003)
Spinal cord atrophy and disability in multiple sclerosis over four years:: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon β-1a (Rebif) treatment trial
X Lin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-lb
MP Sormani et al.
NEUROLOGY (2003)
The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS
M Inglese et al.
NEUROLOGY (2003)
Interferon β-1a in primary progressive MS -: An exploratory, randomized, controlled trial
SM Leary et al.
NEUROLOGY (2003)
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study
NF Kalkers et al.
MULTIPLE SCLEROSIS (2002)
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance
David H. Miller et al.
BRAIN (2002)
Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b
S Narayanan et al.
JOURNAL OF NEUROLOGY (2001)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment
Y Ge et al.
NEUROLOGY (2000)
Share Paper
